Randomised placebo-controlled study of stopping second-line drugs in rheumatoid arthritis
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference36 articles.
1. Chloroquine and hydroxychloroquine therapy in rheumatoid arthritis;Scull;Arthritis Rheum,1962
2. A controlled trial of gold salt therapy in rheumatoid arthritis;Cooperating Clinics Committee of the ARA;Arthritis Rheum,1973
3. Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial;Clark;Ann Intern Med,1993
4. Sulfasalazine in early rheumatoid arthritis. A 48-week double-blind, prospective, placebo-controlled study;Hannonen;Arthritis Rheum,1993
5. Efficacy of low-dose methotrexate in rheumatoid arthritis;Weinblatt;N Engl J Med,1985
Cited by 120 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effects of tapering conventional synthetic disease-modifying antirheumatic drugs to drug-free remission versus stable treatment in rheumatoid arthritis (ARCTIC REWIND): 3-year results from an open-label, randomised controlled, non-inferiority trial;The Lancet Rheumatology;2024-05
2. Erratum to “Predicting drug-free remission in rheumatoid arthritis: A prospective interventional cohort study” [J. Autoimmun. 105 (December 2019) 102298];Journal of Autoimmunity;2022-10
3. Withdrawal of MTX in rheumatoid arthritis patients on bDMARD/tsDMARD plus methotrexate at target: a systematic review and meta-analysis;Rheumatology;2022-09-20
4. EULAR 75-year anniversary: commentaries on ARD papers from 25 years ago;Annals of the Rheumatic Diseases;2022-09-14
5. Efficacy and safety of progressively reducing biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in persistent remission: a study protocol for a non-inferiority randomized, controlled, single-blind trial;Trials;2022-07-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3